Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)

B. I. Freedman, Jean-Paul Wuerth, Kenneth Cartwright, Raymond P. Bain, Stephen E. Dippe, Kenneth S. Hershon, A. D. Mooradian, Bruce S. Spinowitz

Controlled Clinical Trials · 1999 · 255 citations · 35 references

Concepts

References

35